Addressing Evolving Educational Needs on BTK Inhibitor Therapies in CLL/SLL and MCL

Hear expert faculty discuss areas of consensus and controversies on the use of approved and emerging BTK inhibitors in managing CLL and MCL. Review their insights in an on-demand webcast adapted from a live webinar downloadable slideset 2 commentaries and a podcast.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Lilly